| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Eltrombopag |
| Brand | Revolade® |
| Indication | For the treatment adult patients with acquired severe aplastic anaemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pre-treated and are unsuitable for haematopoietic stem cell transplantation. |
| Assessment Process | |
| Full submission received from Applicant | 05/02/2016 |
| NCPE assessment completed | 01/03/2016 |
| NCPE assessment outcome | Full Pharmacoeconomic Evaluation Not Recommended |
